Wall Street set to rise as volatility eases from record levels

Reuters 

By Tanya Agrawal

(Reuters) - U. S. stocks looked set to open about half a percent higher on Thursday, as investors returned their focus to corporate results as eased after hitting its highest level in more than two-and-a-half years earlier in the week.

By 8:32 a.m. ET (1332 GMT), Dow were up 111 points, or 0.45 percent, were up 13 points, or 0.49 percent.

were up 51.75 points, or 0.79 percent, on volume of 79,385 contracts.

Wall Street ran out of steam on Wednesday after an early surge as investors were still cautious after a bruising selloff that saw the post its biggest intraday fall on record on Monday.

The market's main gauge of volatility, the CBOE Index, fell to 26.74 on Thursday, still more than twice levels it held over the past few months. The index hit its highest level since August 2015 on Tuesday.

Investors are weighing whether the sharp swings are the start of a deeper correction or just a temporary bump in the nine-year bull market, spurred by concerns over rising interest rates and bond yields.

"While in the markets has eased over the last couple of days, it has remained at very high levels - probably a sign of the ongoing nervousness among investors which may leave markets vulnerable to further declines," Craig Erlam, at said in a note.

said on Thursday the central could hike rates three times this year and the recent market in itself was not enough to change his base scenario.

and are expected to make appearances at different events later in the day.

The 10-year

yield crept back to 2.83 percent, near Monday's four-year peak of 2.885 percent.

Economic data showed weekly jobless claims fell to 221,000 below the 232,000 rise expected by economists, dropping to its lowest level in nearly 45 years as the labor market tightened further.

Among stocks, jumped 20.8 percent in premarket trading after it reported its first quarterly net profit and topped Wall Street targets as video ad sales rose.

fell 10.5 percent after the world's largest generic drugmaker forecast 2018 would be weaker than analysts estimate as the U. S. generics market continues to deteriorate.

fell 7.3 percent after a host of brokerages cut their price targets on the consumer review website operator's stock following quarterly results.

Tyson Foods, rose 7.7 percent after the No. 1 U. S. meat processor, reported better-than-expected quarterly results.

(Reporting by Tanya Agrawal; Editing by Saumyadeb Chakrabarty)

(This story has not been edited by Business Standard staff and is auto-generated from a syndicated feed.)

First Published: Thu, February 08 2018. 19:42 IST